Play Live Radio
Next Up:
0:00 0:00
Available On Air Stations

Federal Trade Commission Cracks Down On Unproven COVID-19 Treatment

The Federal Trade Commission issued warning letters to several companies that marketed an unproven drug to treat COVID-19. Sales of the nonapproved drug, thymosin alpha-1, were first reported by NPR.

Copyright 2020 NPR

Tom Dreisbach is a correspondent on NPR's Investigations team focusing on breaking news stories.